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A B S T R A C T   
The equine roundworm Parascaris univalens has developed resistance to the three anthelmintic substances most 
commonly used in horses. The mechanisms responsible for resistance are believed to be multi-genic, and 
transport proteins such as the P-glycoprotein (Pgp) family have been suggested to be involved in resistance in 
several parasites including P. univlaens. To facilitate further research into the mechanisms behind drug meta-
bolism and resistance development in P. univalens we aimed to develop an in vitro model based on larvae. We 
developed a fast and easy protocol for hatching P. univalens larvae for in vitro studies, resulting in a hatching rate 
of 92 %. The expression of transport protein genes pgp-2, pgp-9, pgp-11.1, pgp-16.1 and major facilitator super-
family (MFS) genes PgR006_g137 and PgR015_g078 were studied in hatched larvae exposed to the anthelmintic 
drugs ivermecin (IVM) 10− 9 M, pyrantel citrate (PYR) 10− 6 M and thiabendazole (TBZ) 10− 5 M for 24 h. In 
comparison, the expression of these transport protein genes was studied in the anterior end and intestinal tissues 
of adult worms in vitro exposed to IVM, TBZ and PYR, at the same concentrations as larvae, for 3 h, 10 h and 24 h. 
Larval exposure to sub-lethal doses of IVM for 24 h did not affect the expression levels of any of the investigated 
genes, however larvae exposed to PYR and TBZ for 24 h showed significantly increased expression of pgp-9. In 
vitro drug exposure of adult worms did not result in any significant increases in expression of transport protein 
genes. Comparisons of constitutive expression between larvae and adult worm tissues showed that pgp-9, pgp- 
11.1, pgp-16.1 and MFS gene PgR015_g078 were expressed at lower levels in larvae than in adult tissues, while 
pgp-2 and MFS gene PgR006_g137 had similar expression levels in larvae and adult worms. All investigated 
transport protein genes were expressed at higher rates in the intestine than in the anterior end of adult worms, 
except pgp-11.1 where the expression was similar between the two tissues. This high constitutive expression in 
the intestine suggests that this is an important site for xenobiotic efflux in P. univalens. Despite the fact that the 
results of this study show differences in expression of transport protein genes between larvae and adult tissues, 
we believe that the larval assay system described here will be an important tool for further research into the 
molecular mechanisms behind anthelmintic resistance development and for other in vitro studies.   
1. Introduction 
Equine parasitic roundworms in the genus Parascaris have developed 
resistance to the three drug classes most commonly used for treatment: 
benzimidazoles (BZs), such as fenbendazole (FBZ) and thiabendazole 
(TBZ); macrocyclic lactones (MLs), such as ivermectin (IVM); tetrahy-
dropyrimidines (TPs), such as pyrantel. Macrocyclic lactone resistance 
was first reported in the Netherlands in 2002 (Boersema et al., 2002) and 
is now found worldwide, as reviewed by Peregrine et al. (2014). Resis-
tance to the TPs has also been reported in several parts of the world, such 
as the USA (Craig et al., 2007), Australia (Armstrong et al., 2014) and 
Europe (Martin et al., 2018) while few cases of resistance to BZs have so 
far been found only in Australia (Armstrong et al., 2014) and Saudi 
Arabia (Alanazi et al., 2017). This development is alarming since severe 
infections can be lethal to foals and control of the parasite usually relies 
on the use of efficient anthelmintic drugs (Cribb et al., 2006). 
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Despite more than 50 years since the first reported case of drug 
resistance in parasitic nematodes, the knowledge about drug meta-
bolism and resistance development mechanisms is scarce, especially in 
ascarid worms. One reason for this is the lack of in vitro models, 
complicated by the complex life cycle of these parasites, which require a 
host to be completed. In several previous studies of P. univalens (Janssen 
et al., 2013; Martin et al., 2020; Scare et al., 2020), live adult worms 
have been collected from horses at slaughter or from euthanized 
research herd foals. A problem with this approach is that slaughter of 
foals is uncommon and the number of research herds where foals are 
necropsied are limited. In addition, there are no isolated laboratory 
strains available for P. univalens, making comparisons between studies 
difficult due to genetically different populations and unknown resis-
tance phenotypes. An in vitro model based on P. univalens larvae could be 
an option as large numbers of parasite eggs can easily be extracted from 
the faeces of naturally infected foals. However, certain procedures are 
required as ascarid eggs, unlike those of strongyle nematodes, do not 
hatch spontaneously outside their host (Urban et al., 1981; Ponce-Ma-
cotela et al., 2011). Previously, only a few studies of in vitro hatching of 
Parascaris spp. eggs have been made with techniques using glass beads 
resulting in hatching ratios ranging from 48 % - 98 % (Burk et al., 2014; 
Rakhshandehroo et al., 2017) 
The mechanisms of anthelmintic resistance have been suggested to 
be multi-genic, including mutations leading to conformational changes 
in drug targets or changes in expression of target molecule genes. 
Altered metabolism by drug metabolizing enzymes and elevated 
expression of drug efflux pumps have also been suggested (James et al., 
2009; Whittaker et al., 2017). Increased efflux of drugs by transport 
proteins such as the P-glycoprotein (Pgp) family and other ATP-binding 
cassette (ABC) transporters has been suggested to be involved in resis-
tance to several classes of anthelmintic drugs, mainly MLs (Xu et al., 
1998; Dicker et al., 2011; Raza et al., 2016b) but also BZs (Blackhall 
et al., 2008). P-glycoproteins are membrane bound transport proteins 
involved in protecting cells against xenobiotic substances (Schinkel and 
Jonker, 2003). Nematodes express numerous Pgps and several of these 
have been shown to be up-regulated either constitutively in resistant 
strains or in response to drug exposure, however results between 
different studies are ambiguous (Williamson and Wolstenholme, 2012; 
Gerhard et al., 2020). In multidrug-resistant adult and larval Tela-
dorsagia circumcincta pgp-9 was constitutionally up-regulated compared 
to drug sensitive worms (Dicker et al., 2011), while expression of pgp-2 
and pgp-9 were higher in multidrug-resistant Haemonchus contortus larva 
than in susceptible larvae (Williamson et al., 2011). In Cooperia onco-
phora pgp-11 was up-regulated in adult ivermectin (IVM) susceptible 
worms after in vivo exposure to IVM, and in IVM-resistant larvae after in 
vitro IVM exposure (De Graef et al., 2013). In addition, pgp-16 was highly 
up-regulated after in vivo IVM selection of susceptible adult C. oncophora 
(Tyden et al., 2014). 
The Pgp family has been investigated for its involvement in IVM 
resistance in Parascaris spp. in several studies. Janssen et al. (2013) 
found that the constitutive expression of pgp-11.1 was increased in adult 
worms with reduced sensitivity to IVM compared to a random worm 
population. In addition, transgenic expression of Parascaris pgp-11.1 in 
Caenorhabditis elegans led to reduced susceptibility to IVM, strength-
ening the theory that this efflux pump is involved in IVM resistance 
(Janssen et al., 2015). Gerhard et al. (2020) did a thorough investigation 
of the complete Pgp family in P. univalens and found that it contains ten 
genes, and that pgp-2 and pgp-9 interacts with IVM. 
Despite the fact that Pgps and other members of the ABC transporter 
family have been investigated in connection with anthelmintic resistance 
in parasitic nematodes, additional transporters have been shown to be 
involved in other organisms. The major facilitator superfamily (MFS) is a 
large superfamily of membrane transporters present in both prokaryotes 
and eukaryotes, shown to be involved in drug resistance in bacteria and 
yeast (Paulsen et al., 1996). In a previous study, the two MFS genes 
PgR006_g137 and PgR015_g078 were differentially expressed in adult 
P. univalens after in vitro exposure to IVM and pyrantel citrate (PYR), 
indicating that they might respond to anthelminthic drugs in nematodes 
(Martin et al., 2020). 
Since Parascaris spp. have developed resistance to the three anthel-
mintic substances most commonly used in horses there is an urgent need 
to understand the mechanism of resistance development. Here we 
developed a protocol for hatching and use of P. univalens larvae for in 
vitro experiments. The constitutive gene expression of transport proteins 
pgp-2, pgp-9, pgp-11.1, pgp-16.1 and MFS-genes PgR006_g137 and 
PgR015_g078 was compared in P. univalens larvae and different tissues 
of adult worms. In addition, the expression of the transport protein genes 
was investigated after in vitro drug exposure to sub-lethal doses of IVM, 
PYR and TBZ. 
2. Materials and methods 
2.1. Parasite collection 
Adult P. univalens were collected from the intestines of nine foals, 
approximately six months old, at an abattoir in Selfoss, Iceland. The 
horses originated from three farms in the south of Iceland and had never 
been treated with anthelmintic drugs. The resistance phenotypes on the 
farms were not investigated in this study. The worms were rinsed and 
transported to the laboratory (Institute for Experimental Pathology at 
Keldur, University of Iceland, Reykjavík, Iceland) in 37 ◦C PBS (Life 
Technologies, Carlsbad, USA). Eggs were isolated from the uterus of 
P. univalens collected in Selfoss and also from pooled faecal material 
collected in connection with the FECRT in the north and west of Iceland 
(Martin et al., 2021). 
2.2. Constitutive gene expression in larvae and adult worm tissues 
Adult worms were dissected after arrival to the laboratory (Institute 
for Experimental Pathology at Keldur). Anterior end and intestinal tissue 
were placed in RNAlater (Invitrogen, Carlsbad, USA) in individual tubes 
and transported to Sweden (Swedish University of Agricultural Sciences 
(SLU), Department of Biomedical Sciences and Veterinary Public Health, 
Section for Parasitology). Eggs collected during the FECRT were cleaned 
and decorticated by washing in 2 % sodium hypochlorite in 16.5 % 
sodium chloride (Swedish Veterinary Institute (SVA), Uppsala, Sweden) 
and thereafter rinsed six times with cold tap water and resuspended in 
water. The final egg concentration was determined by counting the 
number of eggs in 3 × 10 μL of water using a microscope. The eggs were 
incubated at 25 ◦C for 21 days to allow larvae to develop, then divided 
into three tubes containing approximately 12,000 larvated eggs each, 
pelleted by centrifugation for 5 min at 11,000 × g and flash frozen in 
liquid nitrogen. 
2.3. Hatching, culture and drug-exposure of larvae 
Eggs from the uterus of adult worms collected at Selfoss were cleaned 
and incubated for in ovo larval development as above. The larvated eggs 
were rinsed in PBS containing 0.05 % Tween 20 (VWR, Radnor, USA), 
final volume 5 mL, transferred to a Kimble® Kontes® 15 mL glass ho-
mogenizer (DWK Life Sciences, Mainz, Germany) and hatched by six 
slow strokes with pestle B (leaving 0.16 mm clearance). Hatched larvae 
were centrifuged 5 min at 1,600 × g and resuspended in tissue culture 
media, RPMI-1640 with the addition of 10 % foetal bovine serum, 1 % 
penicillin/streptomycin and 1 % L-glutamine (Life Technologies). 
Hatching ratio was determined by counting 100 larvae/eggs at five 
different hatching experiments and calculated by the formulae: 
Hatching ratio = hatched larvae/(hatched larvae + unhatched larvae) x 100 
The anthelmintic drugs IVM (Sigma-Aldrich, Saint Louis, USA) PYR 
(Santa Cruz Biotechnology, Dallas, USA) and TBZ (Sigma-Aldrich) were 
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dissolved in Dimethyl Sulfoxide (DMSO) (SVA) and serially diluted. The 
number of larvae in 3 × 10 μL tissue culture media were counted to 
calculate the larval concentration, then approximately 4,000 larvae in 1 
mL tissue culture media were dispensed in each well of a 24 well tissue 
culture plate (TTP, Trasadingen, Switzerland) and acclimatised for 24 h 
at 37 ◦C, 5 % CO2 before drug exposure. Larvae (n = 4,000) in triplicate 
wells were then exposed to either IVM 10− 9 M, PYR 10− 6 M, TBZ 10− 5 M 
or without the addition of an anthelmintic drug (control) for 24 h at 37 
◦C, 5 % CO2. The final concentration of DMSO was 0.1 % in all wells. 
Concentrations of anthelmintic drugs used were the same as the highest 
doses used in a previous study where adult worms were found to be 
affected but not killed by 24 h in vitro exposure (Martin et al., 2020). 
After exposure, larvae were collected and centrifuged 5 min at 11,000 ×
g. The larval pellets were then flash frozen in liquid nitrogen. 
2.4. Drug exposure of adult worms 
At the Institute for Experimental Pathology at Keldur, worms were 
incubated at 37 ◦C in tissue culture media and exposed to anthelmintic 
drugs of the same concentrations as in the larval experiment, IVM 10− 9 
M (n = 9), PYR 10− 6 M (n = 9), TBZ 10− 5 M (n = 9) or without the 
addition of an anthelmintic drug (control, n = 9). Anthelmintic drugs 
were dissolved and diluted in DMSO as above. To investigate the 
expressional response at different time points three worms were 
removed from each group and dissected after 3 h, 10 h and 24 h expo-
sure. The anterior end and the intestine were placed in individual tubes 
containing RNAlater. The samples were then transported to Sweden 
(SLU, Department of Biomedical Sciences and Veterinary Public Health, 
Section for Parasitology). 
2.5. RNA extraction and quality control 
Adult worm samples were removed from RNAlater, cut into pieces, 
mixed with 1 mL Trizol (Invitrogen) and homogenized in a glass tissue 
grinder. 200 μL chloroform (Sigma-Aldrich) was added, the sample was 
mixed and then centrifuged at 13,000 × g for 15 min, 4 ◦C. A 100 μL 
aliquot of the upper aqueous phase was mixed with 350 μL lysis buffer 
from the NucleoSpin® RNA Plus kit (Macherey Nagel, Düren, Germany) 
and RNA was isolated as described in the user manual. 
Frozen larval pellets were ground with a pestle after addition of 100 
μL Trizol. After homogenization, the final volume of Trizol was made up 
to 900 μL and mixed with 200 μL chloroform. Each sample was centri-
fuged at 13,000 × g for 15 min, 4 ◦C, and the aqueous phase was split into 
two microfuge tubes. To each tube 200 μL lysis buffer from the Nucleo-
Spin® RNA XS kit (Macherey Nagel) was added and RNA was isolated as 
described in the user manual of the kit, including a DNase step. 
RNA concentration and integrity were checked by TapeStation 
(Agilent, Santa Clara, USA). Then cDNA was synthesized by SuperScript 
III Reverse Transcriptase (Invitrogen), according to the manufacturers 
instruction. To investigate the constitutive expression in larvae and 
adult tissues 18 ng of RNA (RIN 5.9–8.6) was used for each 20 μL cDNA 
reaction. For drug exposed larvae 10 ng of RNA (RIN 7.8–9.2) was used 
for each 20 μL cDNA reaction. For drug-exposed adult worms 75 ng of 
RNA (RIN 8.2–9.4) was treated with DNase I (Invitrogen) according to 
the manufacturer and then used for each 20 μL cDNA reaction. 
2.6. Primer design and validation 
The P. univalens genome (PRJNA386823) in WormBase Parasite 
(Howe et al., 2017) was used to identify genes of interest and reference 
genes (Table 1). Primer sites were picked to flank intron sequences, 
designed using Primer3web (Untergasser et al., 2012) and ordered from 
Eurofins Genomics (Galten, Denmark). PCR reactions containing: 12.5 
μL Accustart II PCR ToughMix (Quanta bio, Beverly, USA), 1 μL each of F 
and R primer (10 μ M each), 9.5 μL H2O and 1 μL template cDNA (un-
exposed adult anterior end) were performed on an Applied Biosystems 
(Foster City, USA) 2721 Thermal Cycler at 94 ◦C for 3 min, followed by 
35 cycles of 94 ◦C for 30 s, 58 ◦C for 30 s and 72 ◦C for 90 s and a final 
extension at 72 ◦C for 9 min. PCR products were confirmed by gel 
electrophoresis, Sanger sequencing (Macrogen Europe, Amsterdam, 
Netherlands) and nucleotide searches in WormBase Parasite (Howe 
et al., 2017). All primers were optimized for qPCR regarding annealing 
temperature and concentration, then validated to a 92.9–99.9 % effi-
ciency (Table 1). Melt curve data confirmed single products for each 
primer pair. 
2.7. Expression of transport protein genes 
qPCR was performed using QuantiTect SYBR® Green PCR kit 
(Qiagen, Hilden, Germany). The cDNA template was diluted 1:2 for 
constitutive expression in larvae and adult worm tissues. For the tran-
scriptional response to in vitro drug exposure in larvae and adult worms 
cDNA template was diluted 1:2 and 1:3 respectively. Dilutions were 
made in DEPC water (Qiagen). Reactions containing 12.5 μL SYBR mix, 
2 μL diluted template, primer concentration according to Table 1 and 
DEPC water up to 25 μL, were run on BioRad (Hercules, USA) CFX Opus 
96. Each sample was run as technical duplicates (constitutive expres-
sion in larvae and adult tissue and in-vitro exposed larvae) or triplicates 
(in-vitro exposed adult worm tissues) and non-template controls were 
included for each gene. The PCR was initiated by a 15 min denaturation 
step at 95 ◦C followed by 40 cycles of 95 ◦C for 15 s, 59 ◦C for 30 s and 
72 ◦C for 30 s with collection of fluorescence data. Melt curve data was 
collected at 0.5 ◦C steps between 65 ◦C and 96 ◦C. Data was analysed 
using BioRad CFX Maestro. 
Table 1 
Primers used for qPCR.  
Putative gene name/superfamily qPCR primer Sequence (5’→3’) WormBase ParaSite ID Product size (bp) Annealing temp (◦C) Efficiency (%) Conc (nM) 
actin a F: TCGTTTTTAGGGGAGGGATG 
R: AAACACCGAGCAAAATGGAG 
PgR070_g023 137 59 99.5 500 
gpd-1 F: ACAGTGGAGAGATGGACGTG 
R: GCCATGCCAGTCAGTTTACC 
PgB20_g009 116 59 97.5 400 
pgp-2 F: TTGATTGCACGATCGAAGAG 
R: GGTACCTTTCTCGCCAACAC 
PgR011_gPgp-2 154 59 92.9 400 
pgp-9 F: AACGAGGATGTCACTGAGGG 
R: TGTGTACCTCGATCACCCAC 
PgR025_gPgp-9 118 59 97.1 400 
pgp-11.1 F: TCCTGCTTGCACTGCTATGT 
R: GACCCCAATAACCGCGAAC 
PgB04_gPgp-11.1 160 59 98.6 500 
pgp-16.1 F: GTTGGATTCGGATTGGGCAT 
R: TGATGAATTTGTCGCTCGCA 
PgR011_gPgp-16.1 142 59 98.5 500 
MFS F: AGACGTTGGGGCGATATTC 
R: GCTTGTTGCTATTCGCTTCA 
PgR006_g137 158 59 97.4 400 
MFS F: GGAGGCTGATGTTTGCATTT 
R: TCCACTGCTCTTCACCATTG 
PgR015_g078 158 59 99.9 400  
a Sequence from Janssen et al. (2013). 
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2.8. Calculation of relative expression and statistical analysis 
Relative expression was calculated in Microsoft Excel 2016 using the 
ΔΔCt-method (Livak and Schmittgen, 2001). Statistical analysis was 
performed using GraphPad Prism 9.1.0. 
2.8.1. Constitutive expression of transport protein genes in larvae and adult 
worm tissues 
The Ct values were normalized to the reference gene gpd-1 since actin 
was not stably expressed in adult intestinal tissue. Expression levels of 
pgp-2, pgp-9, pgp-11.1, MFS genes PgR006_g137 and PgR015_g078 were 
calculated relative to the mean expression in larvae. A one-way ANOVA 
with Tukey’s multiple comparisons test was performed to identify dif-
ferences in expression between tissues and life stages. The expression of 
pgp-16.1 was calculated relative to the mean expression in the anterior 
end. An unpaired t-test was performed to identify differences in 
expression between the intestine and anterior end. 
2.8.2. Transcriptional response of transport protein genes to in vitro drug 
exposure in larvae 
Relative expression compared to the control was calculated with the 
reference genes actin and gpd-1. Significant differences between exposed 
larvae and controls were identified by one-way ANOVA with Tukey’s 
multiple comparisons test. 
2.8.3. Transcriptional response of transport protein genes to in vitro drug 
exposure in adult tissues 
Relative expression compared to the control for each time point was 
calculated with the reference gene gpd-1 for intestinal tissue and refer-
ence genes actin and gpd-1 for anterior end tissue. Two way ANOVAs 
with Tukey’s multiple comparisons test were conducted to determine 
differences in gene expression between treated and control worms and 
between the different time points used for exposure. 
3. Results 
3.1. Constitutive expression of transport protein genes in larvae and 
adult tissues 
The constitutive expression levels of transport protein genes varied 
in adult worm tissues and larvae as shown in Fig. 1. Expression of pgp- 
11.1, and MFS gene PgR015_g078 was significantly higher in both 
anterior end and intestinal tissues of adult worms than in larvae, while 
Fig. 1. Expression levels of transport 
protein genes in tissues from the ante-
rior end and intestine of individual 
adult Parascaris univalens (n = 3) and 
pools of 12,000 larvae (n = 3). Gene 
expression was normalized to the refer-
ence gene gpd-1 and expression levels of 
pgp-2, pgp-9, pgp-11.1 and MFS genes 
PgR006_g137 and PgR015_g078 are 
shown relative to the mean expression 
in larvae. A one-way ANOVA with 
Tukey’s multiple comparisons test was 
performed to identify differences in 
expression between tissues. Expression 
of pgp-16 in larvae was too low to be 
detected, therefore gene expression in 
adult tissues is shown relative to the 
mean expression in the anterior end. An 
unpaired t-test was performed to iden-
tify differences in expression between 
anterior end and intestine. Significant 
differences are marked with * (p <
0.05), ** (p < 0.01), *** (p < 0.001) or 
**** (p > 0.0001).   
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pgp-9 expression was only significantly higher in the intestine compared 
to larvae. In contrast, the MFS gene PgR006_g137 was expressed 
significantly lower in the anterior end tissue compared to larvae whereas 
pgp-2 showed no significant difference in expression levels between 
adult tissues and larvae. The expression of pgp-16.1 was too low to be 
detected in larvae. 
In adult worms, constitutive expression of all transport protein genes 
was significantly higher in the intestine compared to the anterior end 
tissue, except pgp-11.1 that showed no difference in expression between 
the two tissues (Fig. 1). 
3.2. Hatching of P. univalens eggs and transcriptional response of 
transport protein genes to in vitro drug exposure in larvae 
The protocol for hatching P. univalens eggs resulted in a hatching 
ratio of 92 % (SD = 7.4 %) with fully viable larvae for the duration of the 
exposure experiment. 
In vitro exposure to IVM did not significantly affect expression of any 
of the investigated transport protein genes (Fig. 2). However, the 
expression of pgp-9 was significantly increased after exposure to PYR 
and TBZ, while the opposite was observed for pgp-11.1 and MFS gene 
PgR006_g137, where the expression was significantly reduced after 
exposure to PYR and TBZ. Expression of MFS gene PgR015_g078 was 
significantly reduced only after TBZ exposure (Fig. 2). 
3.3. Transcriptional response of transport protein genes to in vitro drug 
exposure in adult tissues 
All adult worms were viable after drug exposure. The expression 
showed rather high variation between the biological replicates (n = 3) 
and no specific pattern was observed after drug exposure (Figs. 3 and 4). 
Interestingly, no transcriptional responses were observed in the 
anterior end after in vitro exposure except for pgp-9, where expression 
was significantly reduced after 24 h of exposure to TBZ compared to the 
24 h control. However, differences in expression between the different 
time points were observed for several genes. Expression of pgp-9 and pgp- 
11.1 increased significantly between the 3 h and 24 h as well as between 
10 h and 24 h time points of IVM exposure, while pgp-16.1 increased 
significantly between 10 h and 24 h time points of IVM exposure. In 
addition, pgp-11.1 expression increased significantly between 3 h and 24 
h time points of PYR exposure, while pgp-9 decreased significantly be-
tween 3 h and 24 h time points of TBZ exposure (Fig. 3). 
The intestinal tissue showed no transcriptional responses after in 
vitro exposure compared to control worms. Expression of the MFS gene 
PgR006_g137 was however increased significantly between 3 h and 24 h 
time points of TBZ exposure (Fig. 4). 
4. Discussion 
Anthelmintic resistance in the equine roundworm P. univalens is an 
increasing problem around the world. Novel in vitro models would 
facilitate further research to better understand how various genes in 
parasitic nematodes respond to anthelmintic drugs and are involved in 
anthelmintic resistance. We have developed a hatching protocol and 
explored an in vitro method to assess how the expression of transporter 
genes in larvae are affected by exposure to anthelmintic drugs. In 
comparison to the hatching protocol for Parascaris spp. presented by 
Burk et al. (2014) the hatching protocol presented here is easy to 
perform and do not require any specialised equipment or incubation 
during the procedure. It results in high hatching ratios (92 %) of larvae 
that are viable in tissue culture media and can be used for in vitro 
experiments. 
Fig. 2. Expressional responses of transport protein genes in pools of 4,000 Parascaris univalens larvae (n = 3) in vitro exposed to IVM 109 M, PYR 10− 6 M, TBZ 10− 5 M 
in media with 0.1 % DMSO or media containing 0.1 % DMSO only (control) for 24 h. Gene expression was normalized to reference genes gpd-1 and actin and related 
to the mean of the control. Significant differences between exposed larvae and controls were identified by one-way ANOVA with Tukey’s multiple comparisons test 
and marked with * (p < 0.05), ** (p < 0.01) or **** (p > 0.0001). 
F. Martin et al.                                                                                                                                                                                                                                  
Veterinary Parasitology 298 (2021) 109535
6
The mechanisms of anthelmintic resistance in parasitic nematodes 
are suggested to be multi-genic and to partly include increased drug 
efflux by transport proteins (James et al., 2009; Whittaker et al., 2017). 
We investigated the difference in constitutive gene expression of various 
Pgp and MFS genes between larvae and adult tissues. Results showed 
that pgp-9, pgp-11.1, pgp-16.1 and the MFS gene PgR015_g078 were 
expressed at lower levels in larvae than in adult tissues, whereas pgp-2 
and MFS gene PgR006_g137 had similar expression levels in the 
different life stages. It is known from previous studies that gene 
expression may differ between larvae and adult stages of parasitic 
worms, as reviewed by Jex et al. (2019). However, to our knowledge, 
there have been no previous studies comparing expression levels of 
transport protein genes between larvae and adult Parascaris spp. In 
agreement with our results, comparisons between P. univalens adult 
worms and eggs as well as between adult H. contortus and larvae showed 
minor differences in expression of pgp-2, while expression of pgp-9, 
pgp-11.1 and pgp-16.1/16 was higher in adult tissues of both parasites 
than in eggs and larvae (Issouf et al., 2014; Gerhard et al., 2020). Thus, 
Fig. 3. Expressional responses of transport protein genes in anterior end tissue of adult Parascaris univalens (n = 3) in vitro exposed to IVM 10− 9 M, PYR 10− 6 M, TBZ 
10− 5 M in media with 0.1 % DMSO or media containing 0.1 % DMSO only (control) for 3 h, 10 h and 24 h. Gene expression was normalized to reference genes gpd-1 
and actin and related to the mean of the control for each time point. Significant differences between drug exposed worms and controls as well as between different 
time points within each treatment group were identified by two-way ANOVA with Tukey’s multiple comparisons test and marked with * (p < 0.05) or ** (p < 0.01). 
Fig. 4. Expressional responses of transport protein genes in intestinal tissue of adult Parascaris univalens (n = 3) in vitro exposed to IVM 10− 9 M, PYR 10− 6 M, TBZ 
10− 5 M in media with 0.1 % DMSO or media containing 0.1 % DMSO only (control) for 3 h, 10 h and 24 h. Gene expression was normalized to reference gene gpd-1 
and related to the mean of the control for each time point. Significant differences between drug exposed worms and controls as well as between different time points 
within each treatment group were identified by two-way ANOVA with Tukey’s multiple comparisons test and marked with * (p < 0.05). 
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differences in gene expression between larvae and adult worms needs to 
be considered when interpreting and comparing results from experi-
ments performed in different life stages. 
In addition to life stage specific differences, expression levels may also 
differ between tissues of adult P. univalens. We found that the constitutive 
expression of pgp-2, pgp-9 and pgp-16.1 were higher in the intestine than 
in the anterior end. In accordance, the same genes were also expressed at 
higher levels in the intestine than the carcass in a tissue specific tran-
scriptome from two male and two female anthelmintic naïve worms 
(Gerhard et al., 2020). However, Janssen et al. (2013) saw a lower 
expression of pgp-16.1 in the intestine than the body wall of male worms, 
while there was no differences between the tissues in female worms. The 
constitutive expression of pgp-11.1 was similar in intestinal and anterior 
end tissue in our study, which is in contrast to Gerhard et al. (2020) 
where pgp-11.1 was expressed at higher levels in the intestine than in the 
carcass. Similarly, Janssen et al. (2013) found significantly higher 
expression of pgp-11.1 in the intestine than the body wall in male worms, 
while female worms had no difference in expression between the tissues, 
which is in agreement with our study. The variation between the studies 
could depend on the differences of the compared tissues (carcass, body 
wall and anterior end vs intestine), differences in experimental design 
and genetic differences between individual worms and populations. Both 
MFS genes, PgR006_g137 and PgR015_g078, were also expressed at 
higher levels in the intestine than in the anterior end. The high consti-
tutive expression of transport proteins in the intestine support the theory 
that this is a major site for xenobiotic efflux in P. univalens (Janssen et al., 
2013; Gerhard et al., 2020). In addition, the fact that expression of P. 
univalens pgp-9 in the intestine of C. elegans led to reduced susceptibility 
of IVM (Gerhard et al., 2021), further indicates that Pgp-expression in the 
intestine may be involved in anthelmintic resistance. 
P-glycoprotein expression has been upregulated in response to 
anthelmintic drug exposure in parasitic nematodes in several studies as 
reviewed by Lespine et al. (2012). Ivermectin is a well-known substrate 
for Pgp-transport and BZs have also been shown to interact with Pgps 
(Nare et al., 1994; Beugnet et al., 1997; Xu et al., 1998), but to our 
knowledge, there are no studies investigating the effects of PYR on 
Pgp-expression or confirming Pgp-transport of PYR so far. It has how-
ever been shown that Pgp-expression can be altered by in vitro exposure 
to both monepantel and levamisole in multidrug resistant strains of 
H. contortus, confirming that several different drugs may affect 
Pgp-expression in nematode larvae (Raza et al., 2016a; Raza et al., 
2016b). P-glycoprotein transport of drug metabolites out of the cell has 
also been suggested as a contributing factor to reduced efficacy of drugs, 
and a metabolite of BZs has been shown to increase expression of pgp-9 
in susceptible H. contortus (James et al., 2009; Kellerova et al., 2020). 
Since P. univalens has developed resistance to the three commonly used 
anthelmintic drugs for horses, we examined the transcriptional response 
of transport proteins after in vitro exposure to IVM, PYR and TBZ. We 
found no significant increases in expression of transport protein genes in 
adult tissues after 3 h, 10 h or 24 h exposure to any of these drugs. These 
results are in accordance with similar studies where no significant 
up-regulation of Pgps was seen after 24 h of exposure to IVM, PYR or 
TBZ (Martin et al., 2020), 3 h of IVM exposure or 24 h exposure to the BZ 
oxibendazole (Scare et al., 2020) as well as 12 h of IVM exposure 
(Janssen et al., 2013; Gerhard et al., 2020). However, pgp-11.1 expres-
sion in the anterior end tissue was increasing slightly during exposure to 
IVM and PYR, with the highest expression levels after 24 h of exposure. 
This suggests that these drugs may have an effect on pgp-11.1 expression, 
but with a delayed response. In a study where mouse liver cells were 
exposed to IVM, a peak of Pgp-expression was observed after 48 h of 
exposure (Menez et al., 2012). In contrast, Raza et al. (2016b) found that 
expression of several Pgps increased in a multi-resistant strain of 
H. contortus larvae after 3 h of exposure to IVM, but then returned to 
basal levels after 6 h. Hence, the timing of transcriptional response 
seems to vary between experiments. Interestingly, there were no sig-
nificant differences in Pgp-expression in intestinal tissue after in vitro 
drug exposure, supporting that the higher constitutive expression in 
intestinal tissue discussed above rather than up-regulation in response to 
drug exposure, may serve as a general defence against anthelmintic 
drugs as well as other xenobiotic substances. 
Exposure of larvae to sub-lethal doses of PYR and TBZ for 24 h 
resulted in a significant increase in pgp-9 expression, but exposure to 
IVM for 24 h did not affect the expression levels of any of the transport 
protein genes studied. A possible reason for the lack of response to IVM 
exposure might be the concentration of the drug. Expression of Pgps 
were found to be dose-dependent both in murine liver cells exposed to 
IVM and in H. contortus larvae exposed to monepantel (Menez et al., 
2012; Raza et al., 2016a). Concentrations of anthelmintic drugs used in 
our study (IVM 109 M, PYR 10− 6 M, TBZ 10− 5 M) were the same as the 
highest concentrations used in a previous study where adult worms were 
found to be affected but not killed by 24 h in vitro exposure (Martin et al., 
2020). To be able to compare the expressional response between larvae 
and adult worms the same drug concentrations were used in both ex-
periments. To our knowledge, there are no previous studies of in vitro 
exposed Parascaris spp. larvae, but in a similar experiment C. oncophora 
larvae of an IVM resistant strain showed an increase of pgp-11 and pgp-16 
expression after 24 h in vitro IVM exposure (De Graef et al., 2013). In 
addition, another study found increases in expression of pgp-2, pgp-9.1 
and pgp-11 after 3 h of IVM exposure in multi-resistant H. contortus 
larvae (Raza et al., 2016b). In conclusion, the transcriptional response of 
Pgps to anthelmintic drug exposure differs in larvae and adult worms. 
Despite these differences, we believe that the model will prove useful to 
compare gene expression levels between larval populations. 
Though the MFS family of multidrug resistance transporters plays a 
major part in antibiotic resistance in bacteria (Fluman and Bibi, 2009), 
little is known about its possible role in anthelmintic metabolism and 
development of resistance in parasitic worms. In a previous study MFS 
gene PgR015_g078 was up-regulated in adult P. univalens after 24 h in 
vitro exposure to IVM, while another MFS gene, PgR006_g137 was 
down-regulated after exposure to IVM and PYR (Martin et al., 2020). In 
the present study, the expression of the MFS genes PgR006_g137 and 
PgR015_g078 were reduced in larvae after 24 h exposure to TBZ while 
PgR006_g137 was also reduced after exposure to PYR. However, there 
were no transcriptional response of MFS genes in adult tissues after in 
vitro exposure. Since up-regulation of several MFS family members are 
known to cause multidrug resistance in bacteria (Fluman and Bibi, 2009) 
we propose that this family of transporter needs to be further investigated 
regarding their possible role in anthelmintic resistance in parasites. 
5. Conclusions 
Similar to other studies of transcriptional responses in P. univalens, 
we did not observe any significant increases in expression of Pgp genes 
in adult worms (Janssen et al., 2013; Gerhard et al., 2020; Martin et al., 
2020; Scare et al., 2020). Interestingly, expression of pgp-9 was 
increased in larvae after exposure to PYR and TBZ, while there was no 
transcriptional responses after IVM exposure. All the investigated 
transport protein genes were expressed at higher rates in the intestine 
than in the anterior end in adult worms, except pgp-11.1 where the 
expression was similar between the two tissues. Whether Pgps are con-
nected to anthelmintic resistance in P. univalens remains to be eluci-
dated, but the high constitutive expression in the intestine support that 
this is an important site for xenobiotic efflux in P. univalens. 
We developed a fast and simple protocol for hatching of P. univalens 
larvae for use in in vitro studies. Though the results of this study show 
differences in expression of transport proteins between larvae and adult 
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tissues, the model could serve as an important tool for further research 
into the molecular mechanisms involved in drug metabolism and 
anthelmintic resistance development. The use of larvae opens up for 
refined study designs with larger and replicated study groups, which is 
difficult to achieve with adult P. univalens worms. The model can be used 
to compare expression of candidate genes between populations with 
different resistance phenotypes and for other types of in vitro studies 
such as trials of novel anthelmintic drugs. 
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for allowing us to collect parasite material and Institute for Experi-
mental Pathology at Keldur, University of Iceland, Reykjavík, Iceland 
for providing laboratory space. We would also like to thank Moa Skarin 
for laboratory assistance and Tom Martin for proofreading of the 
manuscript. 
References 
Alanazi, A.D., Mukbel, R.M., Alyousif, M.S., AlShehri, Z.S., Alanazi, I.O., Al- 
Mohammed, H.I., 2017. A field study on the anthelmintic resistance of Parascaris 
spp. in Arab foals in the Riyadh region, Saudi Arabia. Vet. Q. 37, 200–205. 
Armstrong, S.K., Woodgate, R.G., Gough, S., Heller, J., Sangster, N.C., Hughes, K.J., 
2014. The efficacy of ivermectin, pyrantel and fenbendazole against Parascaris 
equorum infection in foals on farms in Australia. Vet. Parasitol. 205, 575–580. 
Beugnet, F., Gauthey, M., Kerboeuf, D., 1997. Partial in vitro reversal of benzimidazole 
resistance by the free-living stages of Haemonchus contortus with verapamil. Vet. Rec. 
141, 575–576. 
Blackhall, W.J., Prichard, R.K., Beech, R.N., 2008. P-glycoprotein selection in strains of 
Haemonchus contortus resistant to benzimidazoles. Vet. Parasitol. 152, 101–107. 
Boersema, J.H., Eysker, M., Nas, J.W.M., 2002. Apparent resistance of Parascaris equorum 
to macrocyclic lactones. Vet. Rec. 150, 279–281. 
Burk, S.V., Dangoudoubiyam, S., Brewster-Barnes, T., Bryant, U.K., Howe, D.K., 
Carter, C.N., Vanzant, E.S., Harmon, R.J., Kazacos, K.R., Rossano, M.G., 2014. In 
vitro culture of Parascaris equorum larvae and initial investigation of parasite 
excretory-secretory products. Parasitol. Res. 113, 4217–4224. 
Craig, T.M., Diamond, P.L., Ferwerda, N.S., Thompson, J.A., 2007. Evidence of 
ivermectin resistance by Parascaris equorum on a Texas horse farm. J. Equine Vet. 
Sci. 27, 67–71. 
Cribb, N.C., Cote, N.M., Boure, L.P., Peregrine, A.S., 2006. Acute small intestinal 
obstruction associated with Parascaris equorum infection in young horses: 25 cases 
(1985-2004). N. Z. Vet. J. 54, 338–343. 
De Graef, J., Demeler, J., Skuce, P., Mitreva, M., Von Samson-Himmelstjerna, G., 
Vercruysse, J., Claerebout, E., Geldhof, P., 2013. Gene expression analysis of ABC 
transporters in a resistant Cooperia oncophora isolate following in vivo and in vitro 
exposure to macrocyclic lactones. Parasitology 140, 499–508. 
Dicker, A.J., Nisbet, A.J., Skuce, P.J., 2011. Gene expression changes in a P-glycoprotein 
(Tci-pgp-9) putatively associated with ivermectin resistance in Teladorsagia 
circumcincta. Int. J. Parasitol. 41, 935–942. 
Fluman, N., Bibi, E., 2009. Bacterial multidrug transport through the lens of the major 
facilitator superfamily. Biochim. Biophys. Acta 1794, 738–747. 
Gerhard, A.P., Krucken, J., Heitlinger, E., Janssen, I.J.I., Basiaga, M., Kornas, S., Beier, C., 
Nielsen, M.K., Davis, R.E., Wang, J., von Samson-Himmelstjerna, G., 2020. The P- 
glycoprotein repertoire of the equine parasitic nematode Parascaris univalens. Sci. 
Rep. 10, 13586. 
Gerhard, A.P., Krucken, J., Neveu, C., Charvet, C.L., Harmache, A., von Samson- 
Himmelstjerna, G., 2021. Pharyngeal pumping and tissue-specific transgenic P- 
Glycoprotein expression influence macrocyclic lactone susceptibility in 
Caenorhabditis elegans. Pharmaceuticals (Basel) 14. 
Howe, K.L., Bolt, B.J., Shafie, M., Kersey, P., Berriman, M., 2017. WormBase ParaSite - a 
comprehensive resource for helminth genomics. Mol. Biochem. Parasitol. 215, 2–10. 
Issouf, M., Guegnard, F., Koch, C., Le Vern, Y., Blanchard-Letort, A., Che, H., Beech, R.N., 
Kerboeuf, D., Neveu, C., 2014. Haemonchus contortus P-glycoproteins interact with 
host eosinophil granules: a novel insight into the role of ABC transporters in host- 
parasite interaction. PLoS One 9, e87802. 
James, C.E., Hudson, A.L., Davey, M.W., 2009. Drug resistance mechanisms in helminths: 
is it survival of the fittest? Trends Parasitol. 25, 328–335. 
Janssen, I.J., Krucken, J., Demeler, J., Basiaga, M., Kornas, S., von Samson- 
Himmelstjerna, G., 2013. Genetic variants and increased expression of Parascaris 
equorum P-glycoprotein-11 in populations with decreased ivermectin susceptibility. 
PLoS One 8, e61635. 
Janssen, I.J., Krucken, J., Demeler, J., von Samson-Himmelstjerna, G., 2015. 
Transgenically expressed Parascaris P-glycoprotein-11 can modulate ivermectin 
susceptibility in Caenorhabditis elegans. Int. J. Parasitol. Drugs Drug Resist. 5, 44–47. 
Jex, A.R., Gasser, R.B., Schwarz, E.M., 2019. Transcriptomic resources for parasitic 
nematodes of veterinary importance. Trends Parasitol. 35, 72–84. 
Kellerova, P., Raisova Stuchlikova, L., Matouskova, P., Sterbova, K., Lamka, J., 
Navratilova, M., Vokral, I., Szotakova, B., Skalova, L., 2020. Sub-lethal doses of 
albendazole induce drug metabolizing enzymes and increase albendazole 
deactivation in Haemonchus contortus adults. Vet. Res. 51, 94. 
Lespine, A., Menez, C., Bourguinat, C., Prichard, R.K., 2012. P-glycoproteins and other 
multidrug resistance transporters in the pharmacology of anthelmintics: prospects 
for reversing transport-dependent anthelmintic resistance. Int. J. Parasitol. Drugs 
Drug Resist. 2, 58–75. 
Livak, K.J., Schmittgen, T.D., 2001. Analysis of relative gene expression data using real- 
time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402–408. 
Martin, F., Hoglund, J., Bergstrom, T.F., Karlsson Lindsjo, O., Tyden, E., 2018. Resistance 
to pyrantel embonate and efficacy of fenbendazole in Parascaris univalens on Swedish 
stud farms. Vet. Parasitol. 264, 69–73. 
Martin, F., Dube, F., Karlsson Lindsjo, O., Eydal, M., Hoglund, J., Bergstrom, T.F., 
Tyden, E., 2020. Transcriptional responses in Parascaris univalens after in vitro 
exposure to ivermectin, pyrantel citrate and thiabendazole. Parasit. Vectors 13, 342. 
Martin, F., Svansson, V., Eydal, M., Oddsdottir, C., Ernback, M., Persson, I., Tyden, E., 
2021. First report of resistance to ivermectin in Parascaris univalens in Iceland. 
J. Parasitol. 107, 16–22. 
Menez, C., Mselli-Lakhal, L., Foucaud-Vignault, M., Balaguer, P., Alvinerie, M., 
Lespine, A., 2012. Ivermectin induces P-glycoprotein expression and function 
through mRNA stabilization in murine hepatocyte cell line. Biochem. Pharmacol. 83, 
269–278. 
Nare, B., Liu, Z., Prichard, R.K., Georges, E., 1994. Benzimidazoles, potent anti-mitotic 
drugs: substrates for the P-glycoprotein transporter in multidrug-resistant cells. 
Biochem. Pharmacol. 48, 2215–2222. 
Paulsen, I.T., Brown, M.H., Skurray, R.A., 1996. Proton-dependent multidrug efflux 
systems. Microbiol. Rev. 60, 575–608. 
Peregrine, A.S., Molento, M.B., Kaplan, R.M., Nielsen, M.K., 2014. Anthelmintic 
resistance in important parasites of horses: does it really matter? Vet. Parasitol. 201, 
1–8. 
Ponce-Macotela, M., Rodriguez-Caballero, A., Peralta-Abarca, G.E., Martinez- 
Gordillo, M.N., 2011. A simplified method for hatching and isolating Toxocara canis 
larvae to facilitate excretory-secretory antigen collection in vitro. Vet. Parasitol. 175, 
382–385. 
Rakhshandehroo, E., Asadpour, M., Malekpour, S.H., Jafari, A., 2017. The anthelmintic 
effects of five plant extracts on the viabilityof Parascaris equorum larvae. Equine Vet. 
Educ. 29, 219–224. 
Raza, A., Bagnall, N.H., Jabbar, A., Kopp, S.R., Kotze, A.C., 2016a. Increased expression 
of ATP binding cassette transporter genes following exposure of Haemonchus 
contortus larvae to a high concentration of monepantel in vitro. Parasit. Vectors 9, 
522. 
Raza, A., Kopp, S.R., Bagnall, N.H., Jabbar, A., Kotze, A.C., 2016b. Effects of in vitro 
exposure to ivermectin and levamisole on the expression patterns of ABC 
transporters in Haemonchus contortus larvae. Int. J. Parasitol. Drugs Drug Resist. 6, 
103–115. 
Scare, J.A., Dini, P., Norris, J.K., Steuer, A.E., Scoggin, K., Gravatte, H.S., Howe, D.K., 
Slusarewicz, P., Nielsen, M.K., 2020. Ascarids exposed: a method for in vitro drug 
exposure and gene expression analysis of anthelmintic naive Parascaris spp. 
Parasitology 1–26. 
Schinkel, A.H., Jonker, J.W., 2003. Mammalian drug efflux transporters of the ATP 
binding cassette (ABC) family: an overview. Adv. Drug Deliv. Rev. 55, 3–29. 
Tyden, E., Skarin, M., Hoglund, J., 2014. Gene expression of ABC transporters in Cooperia 
oncophora after field and laboratory selection with macrocyclic lactones. Mol. 
Biochem. Parasitol. 198, 66–70. 
Untergasser, A., Cutcutache, I., Koressaar, T., Ye, J., Faircloth, B.C., Remm, M., Rozen, S. 
G., 2012. Primer3–new capabilities and interfaces. Nucleic Acids Res. 40, e115. 
Urban, J.F.J., Douvres, F.W., Tromba, F.G., 1981. A rapid method for hatching Ascaris 
suum eggs in vitro. Proc. Helminthol. Soc. Wash. 48, 241–243. 
Whittaker, J.H., Carlson, S.A., Jones, D.E., Brewer, M.T., 2017. Molecular mechanisms 
for anthelmintic resistance in strongyle nematode parasites of veterinary 
importance. J. Vet. Pharmacol. Ther. 40, 105–115. 
F. Martin et al.                                                                                                                                                                                                                                  
Veterinary Parasitology 298 (2021) 109535
9
Williamson, S.M., Wolstenholme, A.J., 2012. P-glycoproteins of Haemonchus contortus: 
development of real-time PCR assays for gene expression studies. J. Helminthol. 86, 
202–208. 
Williamson, S.M., Storey, B., Howell, S., Harper, K.M., Kaplan, R.M., Wolstenholme, A.J., 
2011. Candidate anthelmintic resistance-associated gene expression and sequence 
polymorphisms in a triple-resistant field isolate of Haemonchus contortus. Mol. 
Biochem. Parasitol. 180, 99–105. 
Xu, M., Molento, M., Blackhall, W., Ribeiro, P., Beech, R., Prichard, R., 1998. Ivermectin 
resistance in nematodes may be caused by alteration of P-glycoprotein homolog. 
Mol. Biochem. Parasitol. 91, 327–335. 
F. Martin et al.                                                                                                                                                                                                                                  
